Integrating pharmacogenetics into society: in search of a model.
作者： Andrew Webster , Paul Martin , Graham Lewis , Andrew Smart
DOI: 10.1038/NRG1430
关键词:
摘要: There has been considerable scientific, corporate and policy interest in the more effective use of genetics both drug development delivery. Pharmacogenetics — study relationship between an individual's genetic makeup response to medicinal drugs attracted global interest, but will it live up its promise? Looking beyond hype that accompanied much commentary area, future pharmacogenetics depend on how competing interests options are resolved.
nature.com
core.ac.uk
york.ac.uk 
sci-hub.se 参考文章(21)
Neil A. Holtzman, Clinical Utility of Pharmacogenetics and Pharmacogenomics Pharmacogenomics. pp. 163- 185 ,(2003) , 10.1002/047142613X.CH9
Allen D. Roses, Pharmacogenetics and the practice of medicine. Nature. ,vol. 405, pp. 857- 865 ,(2000) , 10.1038/35015728
Francis S. Collins, Mark A. Rothstein, Pharmacogenomics : social, ethical, and clinical dimensions Wiley-Liss. ,(2003)
Elias Mossialos, Tom Walley, Monique Mrazek, Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality ,(2004)
Klaus Lindpaintner, Pharmacogenetics and the future of medical practice British Journal of Clinical Pharmacology. ,vol. 54, pp. 221- 230 ,(2002) , 10.1046/J.1365-2125.2002.01630.X
Andrew Smart, Paul Martin, Michael Parker, Tailored medicine: Whom will it fit? The ethics of patient and disease stratification Bioethics. ,vol. 18, pp. 322- 342 ,(2004) , 10.1111/J.1467-8519.2004.00400.X
C. Brazell, A. Freeman, M. Mosteller, Maximizing the value of medicines by including pharmacogenetic research in drug development and surveillance. British Journal of Clinical Pharmacology. ,vol. 53, pp. 224- 231 ,(2002) , 10.1046/J.0306-5251.2001.01556.X
Amalia M. Issa, Ethical perspectives on pharmacogenomic profiling in the drug development process. Nature Reviews Drug Discovery. ,vol. 1, pp. 300- 308 ,(2002) , 10.1038/NRD771
Dalu Mancama, Maria J. Arranz, Robert W. Kerwin, Genetic predictors of therapeutic response to clozapine: current status of research. CNS Drugs. ,vol. 16, pp. 317- 324 ,(2002) , 10.2165/00023210-200216050-00004
David B. Goldstein, Pharmacogenetics in the Laboratory and the Clinic New England Journal of Medicine. ,vol. 348, pp. 553- 556 ,(2003) , 10.1056/NEJME020173